| ID | Name | CAS | Data |
MW (g/mol) |
| 69-859-3 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 1
|
|
2 | 582.96 |
| 69-860-1 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 4
|
|
2 | 582.98 |
| 69-861-0 |
5«beta»-Androst-1-ene-3,17-dione,bis-TMS
|
|
2 | 430.77 |
| 69-892-6 |
Chromium, hexacarbonylbis(«eta»5-2,4-cyclopentadien-1-yl)di-, (Cr-Cr)
|
12194-12-6 |
2 | 402.24 |
| 70-016-6 |
dl-5-Hydroxylysine, N,N,O-tris(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 450.91 |
| 70-124-6 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS
|
|
2 | 538.00 |
| 70-131-8 |
Iron, di-«mu»-carbonyldicarbonylbis(«eta»5-2,4-cyclopentadien-1-yl)di-, (Fe-Fe)
|
12154-95-9 |
2 | 353.92 |
| 70-239-9 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime-TMS
|
|
2 | 650.12 |
| 70-289-4 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime (1)
|
|
2 | 650.12 |
| 70-322-6 |
13,14-Dihydro-15-keto-PGF1A, BO-TMS, isomer # 1
|
|
2 | 644.18 |
| 70-356-9 |
4-Pregnen-11-«beta»,20-«beta»-diol-3-one, MO-TMS
|
|
2 | 505.88 |
| 70-357-8 |
7.alpha.-hydroxy-3-oxo-4-cholesten-26-oate, O-methyloxime, TMS (1)
|
|
2 | 604.04 |
| 70-359-6 |
Silane, [[(3«beta»,5«alpha»,17«beta»)-androstane-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
57711-47-4 |
2 | 520.98 |
| 70-480-1 |
24-Nor-5«beta»-cholane-3«alpha»,7«alpha»,12«alpha»,23-tetrol, TMS
|
|
2 | 669.29 |
| 70-481-0 |
Butanedioic acid, 2,3-bis[(trimethylsilyl)oxy]-, bis(trimethylsilyl) ester, (R*,S*)-
|
38165-94-5 |
2 | 438.81 |
| 70-500-8 |
15(S)-15-Methyl-PGA2, EO-TMS, isomer # 1
|
|
2 | 535.91 |
| 70-504-4 |
3-«alpha»,7-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholestanoic acid, methyl ester, TMS
|
|
2 | 681.22 |
| 70-563-9 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 1
|
|
2 | 658.16 |
| 70-606-1 |
L-(+)-Tartaric acid, bis(trimethylsilyl) ether, bis(trimethylsilyl) ester
|
|
2 | 438.81 |
| 70-607-0 |
2-Glucosyl-cellobiose: aD-Glcp(1->2)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-609-8 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 2
|
|
2 | 639.07 |
| 70-610-6 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 1
|
|
2 | 639.07 |
| 70-611-5 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 4
|
|
2 | 639.08 |
| 70-619-7 |
2H-1-Benzopyran, 3,4-dihydro-2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,5,7-tris[(trimethylsilyl)oxy]-, (2R-trans)-
|
64138-54-1 |
2 | 651.17 |
| 70-658-4 |
5«alpha»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
|
2 | 539.03 |
| 70-690-8 |
3A,11B,17A,21-Tetrahydroxy-5A-pregnan-20-one, MO TMS
|
|
2 | 684.26 |
| 70-720-4 |
Pentanoic acid, 4-hydroxy-2-propyl, bis-TMS, # 1
|
|
2 | 304.58 |
| 70-732-1 |
5-Pregnen-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 505.88 |
| 70-733-0 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 3
|
|
2 | 658.14 |
| 70-768-2 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, benzyloxime (isomer 2)
|
|
2 | 497.80 |
| 70-783-5 |
13,14-Dihydro-15-keto-PGE2, MO-TMS, isomer # 2
|
|
2 | 554.92 |
| 70-791-6 |
Galactotriose: aD-Galp(1->3)-bDGalp(1->4)-DGal, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-807-8 |
Cellotriose: bD-Glcp(1->4)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-808-7 |
Cellotriose: bD-Glcp(1->4)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 70-824-9 |
3,18,20-Trioxo-11«beta»,17«alpha»,21-trihydroxy-4-pregnene, MO-TMS, syn
|
|
2 | 680.11 |
| 70-828-5 |
4-Pregnen-11«beta»,17«alpha»,21-triol-3,20-dione, MO-tris-TMS
|
|
2 | 637.09 |
| 70-841-0 |
5«beta»-Androstan-3«beta»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-842-9 |
5«alpha»-Androstan-3«beta»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-843-8 |
5«beta»-Androstan-3«alpha»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-866-3 |
5-«beta»-Pregnan-3-«alpha»-ol, 20-«alpha»-GlcNAc MeTMS
|
|
2 | 812.43 |
| 70-867-2 |
5-«alpha»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 2
|
|
2 | 812.43 |
| 70-868-1 |
5-«alpha»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 1
|
|
2 | 812.43 |
| 70-869-0 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 1
|
|
2 | 812.43 |
| 70-870-8 |
5-«alpha»-Pregnan-3-«alpha»-ol, 20-«alpha»-GlcNAc, MeTMS
|
|
2 | 812.43 |
| 70-895-1 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, MSTFA-adduct, OH-TMS, # 1
|
|
2 | 513.74 |
| 70-944-6 |
15(S)-15-Methyl-PGA2, MO-TMS, isomer # 2
|
|
2 | 521.88 |
| 70-947-3 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy, 5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 681.22 |
| 70-969-9 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy cholestan-23-en-26-oic acid, isomer # 3, Me-TMS
|
|
2 | 679.21 |
| 70-970-7 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy cholestan-23-en-26-oic acid, isomer # 2, Me-TMS
|
|
2 | 679.21 |
| 70-973-4 |
DL-Ornithine, N,N'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 474.94 |
| 70-993-2 |
17-OH-16«beta»,17-H2 GA53 methyl ester TMS ether
|
|
2 | 538.86 |
| 71-013-8 |
Phosphoric acid, bis[2,3-bis[(trimethylsilyl)oxy]propyl] trimethylsilyl ester
|
32046-28-9 |
2 | 607.06 |
| 71-030-9 |
Silica-1,3,5,7,8-pentamethyl-2,4,6-triethylporphyrine complex, bis-OTMS
|
|
2 | 671.11 |
| 71-145-2 |
3-Oxo-7«alpha»,12«alpha»-dihydroxy-4-cholenic acid, methyl ester, TMS
|
|
2 | 635.11 |
| 71-159-7 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 2
|
|
2 | 812.43 |
| 71-341-4 |
Pregnan-11-one, 3,17,20,21-tetrakis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20R)-
|
56196-47-5 |
2 | 655.22 |
| 71-367-6 |
Mannose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, D-
|
|
2 | 541.07 |
| 71-391-9 |
Mannose, 6-deoxy-2,3,4,5-tetrakis-O-(trimethylsilyl)-, L-
|
|
2 | 452.89 |
| 71-404-4 |
D-Fructose, 1,3,4,5,6-pentakis-O-(trimethylsilyl)-, O-methyloxime
|
56196-14-6 |
2 | 570.10 |
| 71-436-9 |
Silane, [(3«beta»,5«alpha»,11«beta»,17«alpha»,20R)-pregnane-3,11,17,20,21-pentaylpentakis(oxy)]pentakis[trimethyl-
|
57456-94-7 |
2 | 729.41 |
| 71-511-5 |
D-Arabino-Hexonic acid, 3-deoxy-2,5,6-tris-O-(trimethylsilyl)-, «gamma»-lactone
|
33648-66-7 |
2 | 378.68 |
| 71-558-4 |
7-«alpha»,17-«alpha»-Dimethyl-5-«beta»-Androstane-3-«alpha»,17-«beta»-diol, per-TMS
|
|
2 | 464.87 |
| 71-681-7 |
Pregnane-3,20-dione, 11-[(trimethylsilyl)oxy]-, bis(O-methyloxime), (5«beta»,11«beta»)-
|
57305-27-8 |
2 | 462.74 |
| 71-783-4 |
Dehydrochlorotestosterone (Androst-1,4-dien-17A-methyl-4-chloro-17B-ol-3-one), TMS
|
|
2 | 479.24 |
| 71-822-0 |
Silane, [[2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triyl]tris(oxy)]tris[trimethyl-, (2R-cis)-
|
89267-68-5 |
2 | 651.17 |
| 71-885-1 |
D-Erythro-Pentonic acid, 2-deoxy-3,5-bis-O-(trimethylsilyl)-, «gamma»-lactone
|
10589-33-0 |
2 | 276.48 |
| 72-002-9 |
Pregnan-20-one, 3,11,21-tris[(trimethylsilyl)oxy]-, O-methyloxime, (3«alpha»,5«beta»,11«beta»)-
|
32206-68-1 |
2 | 596.08 |
| 72-023-6 |
2,2,4,4,6,6,8,8-octamethyl-10,10,12,12-tetraphenyl-[1,3,5,7,9,11,2,4,6,8,10,12]cyclohexasiloxane
|
|
2 | 693.20 |
| 72-074-0 |
Tert-butyldimethylsilyl 2,2,3,3-tetramethyl-4,7,10,13,16,19,22,25,28,31-decaoxa-3-silatritriacontan-33-oate
|
|
2 | 701.06 |
| 72-143-3 |
Benzoic acid, 2-hydroxy, 3-(2,3-dioxypropyl), bis-DTBS
|
|
2 | 492.80 |
| 72-313-4 |
N-Acetyl-L-aspartic acid, N-(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 517.92 |
| 72-334-1 |
Pentanoic acid, 3,5-bis[(tert-butyldimethylsilyl)oxy]-3-methyl-, tert-butyldimethylsilyl ester
|
|
2 | 490.94 |
| 72-345-9 |
1H-naphth[1,2-d]imidazole, 1-(p-anisidino)-2-phenyl-
|
13750-96-4 |
2 | 365.43 |
| 72-380-0 |
3-(N,n-di-n-hexylamino)-2-methyl-5-(n-heptyl)-pyrazine
|
116403-06-6 |
2 | 375.63 |
| 72-398-1 |
Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form)
|
|
2 | 556.46 |
| 72-408-9 |
2-(N,n-di-n-pentylamino)-3-methyl-6-(n-heptyl) pyrazine
|
116402-83-6 |
2 | 347.58 |
| 72-459-3 |
tert-Butyl-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 466.80 |
| 72-460-1 |
L-Asparagine, N,N2-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
96381-41-8 |
2 | 474.90 |
| 72-510-5 |
D-Ribose, 2,3,4-tris-O-(trimethylsilyl)-, O-methyloxime, 5-[bis(trimethylsilyl) phosphate]
|
55319-74-9 |
2 | 620.06 |
| 72-590-7 |
2-(N,n-di-n-butyl amino)-3-(5-nonyl) pyrazine
|
|
2 | 333.56 |
| 72-728-4 |
2,4,6,8,10-pentamethyl-2,4,6,8,10-penta(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 565.95 |
| 72-740-0 |
Copper, bis(2,2,6-trimethyl-3,5-heptanedionato-O,O')-
|
41752-16-3 |
2 | 402.03 |
| 73-200-8 |
V-triazolo[5,4-d]-v-triazin-7(6h)-one
|
4730-53-4 |
2 | 138.09 |
| 73-403-3 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2,6-dimethoxy-phenol, TES
|
|
2 | 616.98 |
| 73-589-8 |
Tert-butyldimethylsilyl 2,2,3,3-tetramethyl-4,7,10,13,16,19,22,25,28-nonaoxa-3-silatriacontan-30-oate
|
|
2 | 656.99 |
| 73-595-1 |
3-oxo-4,6-cholesten-26-oate, O-methyloxime-TMS
|
|
2 | 513.83 |
| 73-601-3 |
4-(7-Ethyl-3-methyl-5-propenyl-2,3-dihydro-benzofuran-2-yl)-2,6-dimethoxy-phenol, TPS
|
|
2 | 510.78 |
| 73-618-5 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-PFP
|
|
2 | 724.70 |
| 73-624-8 |
Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)cobalt
|
14877-41-9 |
2 | 608.74 |
| 73-628-4 |
7«alpha»-hydroxy-3-oxo-4-chol-24-oate, oxime-TMS
|
|
2 | 620.10 |
| 73-716-6 |
1H-naphth[1,2-d]imidazole, 1-(p-bromoanilino)-2-(p-nitrophenyl)-
|
14135-28-5 |
2 | 459.30 |
| 73-718-4 |
3H-naphth[1,2-d]imidazole, 3-(p-nitroanilino)-2-(p-nitrophenyl)-
|
|
2 | 425.40 |
| 73-864-2 |
N,n'-bis-(4-(6-methyl)1,3,3a,7-tetrazaindenyl)-hexamethylenediamine
|
|
2 | 380.46 |
| 73-865-1 |
2-Pyridinecarbamic acid, 6-amino-4-[[2-hydroxy-3-(methylphenylamino)propyl]amino]-5-nitro-, ethyl ester
|
|
2 | 404.43 |
| 74-083-8 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)nonyloxy-
|
|
2 | 432.47 |
| 74-115-2 |
N-beta-hydroxyethyl-n,n'-bis-(4-(6-methyl)-1,3,3a,7-tetrazaindenyl)ethylenediamine
|
111472-54-9 |
2 | 368.40 |
| 74-187-3 |
N,n'-bis-(4-(6-methyl)1,3,3a,7-tetrazaindenyl)-ethylenediamine
|
100883-07-6 |
2 | 324.34 |
| 74-407-8 |
5,5'-Methylene-bis(2-keto-1,3-dimethyltetrahydro-1,3,5-triazine
|
126591-36-4 |
2 | 270.33 |
| 74-617-5 |
2-O-(2-(4-hydroxyphenyl)-ethyl)-d-«beta»-glucopyranose, 5TMS
|
1036766-19-4 |
2 | 661.21 |
| 74-769-7 |
Cyclohexanecarboxylic acid, 1-[3-(2-chloroethyl)ureido]-3-methyl-, ethyl ester
|
33190-16-8 |
2 | 290.79 |
|
« Previous Results
Next Results »
|